Mark L. Pacala's Insider Trades & SAST Disclosures

Mark L. Pacala's most recent trade in Oncology Institute Inc (The) was a trade of 90,562 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on March 26, 2025.

Share

Note

This is a custom search result for pattern Mark L. Pacala.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Oncology Institute Inc (The)	Mark L. Pacala	Director	Purchase of securities on an exchange or from another person at price $ 1.04 per share.	26 Mar 2025	90,562	224,971	-	1.0	94,338	Common Stock
Oncology Institute Inc (The)	Mark L. Pacala	Director	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	26 Mar 2025	42,281	42,281	-		-	Common Warrant
Oncology Institute Inc (The)	Mark L. Pacala	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Nov 2024	50,000	134,409	-		0	Common stock
Oncology Institute Inc (The)	Mark L. Pacala	Director	Other type of transaction at price $ 0.00 per share.	12 Nov 2024	30,372	84,409	-		0	Common stock
Oncology Institute Inc (The)	Mark L. Pacala	Director	Other type of transaction at price $ 0.00 per share.	12 Nov 2024	20,248	114,781	-		0	Common stock
Oncology Institute Inc (The)	Mark Pacala L.	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Dec 2023	46,630	135,029	-		0	Common stock
Oncology Institute Inc (The)	Mark L. Pacala	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Mar 2023	6,562	88,399	-		0	Common stock
Oncology Institute Inc (The)	Mark L. Pacala	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Nov 2022	29,057	81,837	-		0	Common Stock
Oncology Institute Inc (The)	Mark L. Pacala	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Nov 2022	2,160	52,780	-		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades